#Personalized Cancer Vaccine

Moderna Stock Surges: Can Its Cancer Vaccine Change the Future of MRNA?

Moderna stock surged after its personalized mRNA cancer vaccine delivered positive Phase 3 results in melanoma patients. Here's what the breakthrough could mean for MRNA stock and Moderna's future.